Fitalent

fitalent.com ↗ ·Madrid ·Invests Seed – Series A

Closed: website domain for sale, no investment since March 2024. Fitalent no longer appears in the directory or on the maps; its funding history is kept below.

Fitalent is the corporate venture capital fund of NTT DATA (formerly everis group), based in Madrid, Spain, founded in 2011. It invests in early-stage, technology-based Spanish startups where people and talent are the core asset, operating through three strategic lines launched in 2017: Venture Capital, Corporate Venturing, and Company Builder. The fund has backed around 19 companies including Irisbond, Palobiofarma, SATLANTIS and AbilityPharma.

Tracked portfolio

AUM

n/a

Rounds

Cheque

€150K–750K

SectorsHealth, Enterprise Software, Life Sciences/Biotech, Transportation, Digital Business VC MapCorporate VC

Suggest a correction

Team

No names on record yet.

Portfolio companies 10

Open 7 as list → On map →

Ability Pharmaceuticals

entered at Series A, 2019

Healthtech & Bio Series A

Oncostellae

entered at Series A, 2022

Healthtech & Bio Series A

Medibiofarma

entered at Seed, 2022

Healthtech & Bio Seed

Boxmotions

led Seed, 2020

Mobility & Logistics Seed

Irisbond

entered at Seed, 2015

Healthtech & Bio Series C

Palobiofarma

led Series C, 2013

Healthtech & Bio Series C

Citibeats

per company site

AI & Data Seed

Exited or sunsetted (3)

BooBoo

per company site

Closed in 2026

Signadyne

per company site

Acquired by Keysight Technologies, 2016

Spectrapply

per company site

Closed

Funding rounds 8

Open as list →

Date	Company	Round	Amount	Lead
2024-03-11	Ability Pharmaceuticals	Series A (estimated)	€7M	CTI Life Sciences Fund +7 more
2022-07-04	Oncostellae	Series A (estimated)	€3.3M	Lead not disclosed +7 more
2022-03-15	Medibiofarma	Seed (estimated)	€1.2M	Lead not disclosed +3 more
2020-01-10	Boxmotions	Seed (estimated)	€2.4M	Fitalent, Castel Capital, Finaves +4 more
2019-09-12	Ability Pharmaceuticals	Series A (estimated)	€3.5M	Lead not disclosed +3 more
2015-03-02	Irisbond	Seed	€300K	Lead not disclosed +2 more
2013-06-19	Palobiofarma	Series C (estimated)	€4.5M	Sodena, Fitalent, Inveready Biotech II +1 more
2012-06-15	Palobiofarma	Seed (estimated)	€1M	Lead not disclosed +3 more

Often invests with 12

Open as list →

Inveready 7 Capital Cell 3 Sodena 2 Athos Capital 1 Centro para el Desarrollo Tecnológico y la Innovación 1 Dozen Investments 1

News 3

Open as list →

Published	Article
2024-03-11	AbilityPharma Announces €7 Million Financing Round to Advance Development of its Clinical Phase 2b Autophagy Inducer ABTL0812 in Metastatic Pancreatic Cancer ↗ PR Newswire 2024-03-11
2024-02-02	Palobiofarma closes a €7M round with the participation of Inveready, Sodena and the Promotor team ↗ Capital-Riesgo.es (English) 2024-02-02
2023-08-24	The Galician biopharmaceutical Oncostellae opens an office at the Barcelona Science Park ↗ AseBio 2023-08-24